These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 1964076)

  • 21. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation.
    Braun L; Mikumo R; Fausto N
    Cancer Res; 1989 Mar; 49(6):1554-61. PubMed ID: 2647288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
    Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
    Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of transforming growth factor alpha messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones.
    Raymond VW; Lee DC; Grisham JW; Earp HS
    Cancer Res; 1989 Jul; 49(13):3608-12. PubMed ID: 2786455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of growth factor systems in transformed airway epithelial cells.
    Nettesheim P; Ferriola PC; Robertson AT; Iwanaga T; Steigerwalt R; Rundhaug JE
    Princess Takamatsu Symp; 1991; 22():171-81. PubMed ID: 1844239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
    Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
    Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.
    Siepl C; Malipiero UV; Fontana A
    J Immunol; 1991 May; 146(9):3063-7. PubMed ID: 1849940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of transforming growth factor beta on rat hepatocyte cell lines depends upon the state of tumorigenic progression.
    Reeder MK; Isom HC
    Cell Growth Differ; 1996 Apr; 7(4):449-60. PubMed ID: 9052986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
    Satterwhite DJ; Aakre ME; Gorska AE; Moses HL
    Cell Growth Differ; 1994 Aug; 5(8):789-99. PubMed ID: 7986745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
    Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
    Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
    Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
    Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
    De Benedetti F; Falk L; Ruscetti FW; Colburn NH; Faltynek CR; Oppenheim JJ
    Cancer Res; 1991 Feb; 51(4):1158-64. PubMed ID: 1847657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia.
    Grasl-Kraupp B; Rossmanith W; Ruttkay-Nedecky B; Müllauer L; Kammerer B; Bursch W; Schulte-Hermann R
    Hepatology; 1998 Sep; 28(3):717-26. PubMed ID: 9731564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of transforming growth factor beta 1 (TGF-beta 1)-induced growth arrest and p34cdc2 regulation in ras-transfected epithelial cells.
    Longstreet M; Miller B; Howe PH
    Oncogene; 1992 Aug; 7(8):1549-56. PubMed ID: 1630817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2.
    Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD
    Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.